MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0001976
Chemeca Drugs Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹127.59 Cr
▲ 5% YoY
Net profit · FY 2025
₹3.86 Cr
Net margin 3%
EBITDA · FY 2025
₹9.43 Cr
EBITDA margin 7.4%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹7.61 Cr
Issued & subscribed
Open charges
₹52.63 Lakh
Satisfied ₹15.24 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
180
Provident fund records
About Chemeca Drugs Private Limited
Data last updated:
Chemeca Drugs Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 October 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP2003PTC041849. Its GSTIN is 37AABCV8147R1ZG (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.61 Cr. It was formerly known as Vegesna Laboratories Private Limited. It is led by directors including Pailla Malla Reddy (Managing Director) and Saketh Reddy Pailla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 7 J.N.Pharamacity Tadi Village Parawada Mandal, Visakhapatnam, Andhra Pradesh, India – 531021.
As per the financials filed for FY 2025, the company reported a revenue of ₹127.59 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹3.86 Cr (net margin 3%) and EBITDA of ₹9.43 Cr (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 20% over five years.
The company has about 180 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Chemeca Drugs. As per MCA filings, the company has open charges of ₹52.63 Lakh and satisfied charges of ₹15.24 Cr on record. Court records list 14 cases involving the company, including 11 filed by the company and 3 filed against it; 4 cases are pending.
Chemeca Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0001976). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chemeca.com.
Company details
CIN U24239AP2003PTC041849
Registration Number 041849
Incorporation Date 10 October 2003
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0001976
CIN history
Chemeca Drugs has one previous CIN (Corporate Identification Number): U24239TG2003PTC041849. The current CIN is U24239AP2003PTC041849, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239AP2003PTC041849 | Current |
| U24239TG2003PTC041849 | Previous |
Key People
Pailla Malla Reddy Managing Director Saketh Reddy Pailla Director Venkata Siva Reddy Pallempalli Director Recognitions & Rankings of Chemeca Drugs
Contact details
Chemeca Drugs Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is chemeca.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 7 J.N.Pharamacity Tadi Village Parawada Mandal, Visakhapatnam, Andhra Pradesh, India – 531021
- IndustryPharma, API Manufacturers
To see the full contact details of Chemeca Drugs Private Limited, buy the company report.
Comprehensive company report
Chemeca Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Chemeca Drugs operates one associated brand: Chemeca Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of active pharmaceutical ingredients and drug intermediates in India. | chemeca.com |
Business activity
The main business activity of Chemeca Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Chemeca Drugs Private Limited, buy the company report.
Financials of Chemeca Drugs Private Limited
FY 2025 filings availableChemeca Drugs Private Limited reported revenue of ₹127.59 Cr (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹127.59 Cr ▲ 5%
Net profit · FY 2025
₹3.86 Cr margin 3%
EBITDA · FY 2025
₹9.43 Cr margin 7.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 34%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 63%
5 years · compounded
▲ 51%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 5% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.86 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chemeca Drugs Private Limited, buy the company report.
Board of directors of Chemeca Drugs Private Limited
Chemeca Drugs has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saketh Reddy Pailla Also directs: Bactolac Nutraceuticals Private Limited, Azura Plastics Private Limited, Sciegen Pharmaceuticals India Private Limited and 3 more | Director | 02 Aug 2021 | 5 Years 3 Months | Current |
| Venkata Siva Reddy Pallempalli Also directs: Sciegen Pharmaceuticals India Private Limited | Director | 27 Jul 2018 | 8 Years 3 Months | Current |
| Alla Bhaskara Reddy Also directs: Bactolac Nutraceuticals Private Limited, Azura Plastics Private Limited, Sciegen Pharmaceuticals India Private Limited and 2 more | Director | 14 Sep 2017 | 9 Years 1 Months | Current |
| Pailla Malla Reddy Also directs: Bactolac Nutraceuticals Private Limited, Azura Plastics Private Limited, Sciegen Pharmaceuticals India Private Limited and 1 more | Managing Director | 04 Oct 2017 | 9 Years 1 Months | Current |
Peer comparison
Chemeca Drugs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maithri Drugs Private Limited | ₹131.9 Cr (FY 2024) | 14.0% | Hyderabad, Telangana, India | |||
| B E C Chemicals Private Limited | ₹130.65 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Envee Drugs Private Limited | ₹128.76 Cr (FY 2025) | 17.0% | Nadiad, Gujarat, India | |||
| SV Plastochem Private Limited | ₹127.64 Cr (FY 2024) | Nashik, Maharashtra, India | ||||
| Chemeca Drugs Private Limitedthis company | ₹127.59 Cr (FY 2025) | ₹3.86 Cr | 3% | 5.0% | 180 | Visakhapatnam, Andhra Pradesh, India |
| Apex Healthcare Limited | ₹127.54 Cr (FY 2025) | 64.0% | Surat, Gujarat, India | |||
| Coral Drugs Private Limited | ₹126.9 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Sohan Healthcare Private Limited | ₹126.69 Cr (FY 2025) | 6.0% | Yavatmal, Maharashtra, India | |||
| Corey Organics Private Limited | ₹126.33 Cr (FY 2025) | -6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Chemeca Drugs Private Limited, buy the company report.
Auditor
Chemeca Drugs Private Limited is audited by V.M.G.K.MURTY & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.M.G.K.MURTY & CO | FY 2024 | 002223S |
Shareholding
The shareholding of Chemeca Drugs Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chemeca Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹52.63 Lakh
Satisfied charges
₹15.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Dec 2024 | 101053215 | Hdfc Bank Limited | ₹22.63 Lakh | Open | |
| 30 Sep 2024 | 100992049 | Hdfc Bank Limited | ₹30 Lakh | Open | |
| 31 Mar 2014 | 10495843 | Reliance Capital Ltd | ₹51.3 Lakh | Satisfied | |
| 30 Jun 2013 | 10439521 | Reliance Capital Ltd | ₹62.8 Lakh | Satisfied | |
| 13 Oct 2006 | 10050321 | Axis Bank Limited | ₹12.3 Cr | Satisfied |
To see the full charge records of Chemeca Drugs Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Chemeca Drugs Private Limited has 14 court cases on record: 11 filed by Chemeca Drugs, 3 filed against it. 4 cases are pending and 10 are disposed.
Total cases
14
Filed by the company
11
Filed against the company
3
Pending
4
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 3 | 4 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Court case (CC-NI) | Filed by the company against Chemsol Labs Pvt Ltd | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd. and 1 other | Disposed |
| District court, Medchal Malkajgiri, Telangana | Court case (CC.NI) | Filed by the company against Chemsol Labs Pvt Ltd | Disposed |
| District court, Rangareddy, Telangana | Court case (CC-NI) | Filed by the company against RJ Pharma | Pending |
| District court, Rangareddy, Telangana | Court case (CC-NI) | Filed by the company against an individual | Pending |
To see the full case history of Chemeca Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Chemeca Drugs Private Limited has 3 MSME Form 1 returns on record between 2019 and 2021, listing 174 overdue payments to 17 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 17)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Sri Bhargavi Ammonia & Chemicals Private Limited | |||
| Sanjay Chemicals (India) Private Limited | |||
| Analys Lab Private Limited | |||
| Mytri Engineering Services |
To see the full MSME payment records of Chemeca Drugs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Chemeca Drugs Private Limited has a workforce of 180 employees on its EPFO records as of Jan 03, 2025, across 1 active EPFO establishment.
Employee count
180
Active EPFO establishments
1
Employee growth
4.05%
GST
Chemeca Drugs has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AABCV8147R1ZG | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Chemeca Drugs Private Limited, buy the company report.
Recent activity
Chemeca Drugs Private Limited has 7 board changes on record since 2017: 4 appointments and 3 cessations. The latest: Saketh Reddy Pailla was appointed as Director on 02 Aug 2021.
AGM
Chemeca Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Chemeca Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101053215 was registered on 09 Dec 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100992049 was registered on 30 Sep 2024.
Appointed
Saketh Reddy Pailla was appointed as Director.
Ceased
Shruti Gupta ceased to be Company Secretary.
Appointed
Venkata Siva Reddy Pallempalli was appointed as Director.
Ceased
Venkata Suryanarayana Raju Vegesna ceased to be Director.
Charges
A charge registered on 31 Mar 2014 via Charge ID 10495843 with Reliance Capital Ltd was fully satisfied on 02 Nov 2017.
Ceased
Padmavathi Vegesna ceased to be Director.
Charges
A charge registered on 13 Oct 2006 via Charge ID 10050321 with Axis Bank Limited was fully satisfied on 11 Oct 2017.
Appointed
Pailla Malla Reddy was appointed as Managing Director.
15 earlier events are in the company report.
Frequently asked questions
Chemeca Drugs is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 October 2003 (23+ years old) and is registered under CIN U24239AP2003PTC041849.
Chemeca Drugs has 4 current directors:
- Pailla Malla Reddy - Managing Director
- Saketh Reddy Pailla - Director
- Venkata Siva Reddy Pallempalli - Director
- Alla Bhaskara Reddy - Director
The latest financial statements of Chemeca Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Chemeca Drugs is 37AABCV8147R1ZG, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Chemeca Drugs is U24239AP2003PTC041849. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemeca Drugs has 14 court cases on record: 11 filed by the company and 3 filed against it. 4 are pending. Most are in the district courts.
Chemeca Drugs was incorporated on 10 October 2003, making it 23+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Chemeca Drugs by revenue are Maithri Drugs Private Limited, B E C Chemicals Private Limited, Envee Drugs Private Limited, SV Plastochem Private Limited, Apex Healthcare Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Saketh Reddy Pailla was appointed as Director on 02 Aug 2021. Shruti Gupta ceased to be Company Secretary on 30 Apr 2020. Venkata Siva Reddy Pallempalli was appointed as Director on 27 Jul 2018. Chemeca Drugs has 7 board changes on record in total.
Yes, Chemeca Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0001976).
Chemeca Drugs has 3 MSME Form 1 returns on record between 2019 and 2021, listing 174 overdue payments to 17 micro and small suppliers. The latest return was filed on 13 May 2021.
Chemeca Drugs can be reached through the website chemeca.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages